ConductScience.org, home

Paper34673293

Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).

Sader HS and 4 others. Diagn Microbiol Infect Dis, 2022. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020). Papers, record 34673293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34673293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
PubMed
Journal
Diagn Microbiol Infect Dis
PubMed
Year
2022
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
4.94
iCite
Revised in PubMed
2021-12-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sader HSHelio S
2Mendes RERodrigo E
3Streit JMJennifer M
4Carvalhaes CGCecilia G
5Castanheira MMariana

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Gram-Negative BacteriaMajor topic
Drug Resistance, Bacterial
Gram-Negative Bacterial Infections
Hospitals
Humans
Intensive Care Units
Microbial Sensitivity Tests
United States

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42859498Genomic epidemiology of multidrug-resistant Klebsiella pneumoniae reveals lineage-specific resistance patterns with limited virulence determinants.AIMS Microbiol2026https://conductscience.org/library/papers/42859498PubMed
42534385Phenotypic and Genotypic Characterization of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: Co-Existence of blaOXA-23 and blaNDM-1 in a Vietnamese Tertiary Hospital.Int J Microbiol2026https://conductscience.org/library/papers/42534385PubMed
41959558
Development and validation of an interpretable machine learning-based model for predicting carbapenem-resistant Acinetobacter baumannii infection in postoperative ICU patients: a retrospective cohort study.
Front Cell Infect Microbiol2026https://conductscience.org/library/papers/41959558PubMed
41278469
CRAB-RSS: development and validation of a single-center risk stratification model for carbapenem-resistant Acinetobacter baumannii in ICU patients based on mechanical ventilation, carbapenem exposure, and hospitalization duration.
Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41278469PubMed
41156790Trends in the Antimicrobial Resistance Pattern of Bacterial Gram-Negative Pathogens in Elderly Patients Admitted to the Intensive Care Unit.Microorganisms2025https://conductscience.org/library/papers/41156790PubMed
41065368Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa.Clin Microbiol Rev2025https://conductscience.org/library/papers/41065368PubMed
40655052Multidrug Resistance Gram-negative Bacteria in Intensive Care Unit of Tertiary Care Hospital: A Descriptive Cross-sectional Study.JNMA J Nepal Med Assoc2024https://conductscience.org/library/papers/40655052PubMed
40558128Efficacy of Endolysin LysAB1245 Combined with Colistin as Adjunctive Therapy Against Colistin-Resistant Gram-Negative Bacteria.Antibiotics (Basel)2025https://conductscience.org/library/papers/40558128PubMed
40001421Difficult-to-Treat Pseudomonas aeruginosa Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal.Antibiotics (Basel)2025https://conductscience.org/library/papers/40001421PubMed
39680587Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.PLoS One2024https://conductscience.org/library/papers/39680587PubMed
39617865Trends in Bacterial Distribution and Antimicrobial Resistance in Intensive Care Units of Hubei Province, China: A Four-year Surveillance Study (2020-2023).Curr Med Sci2024https://conductscience.org/library/papers/39617865PubMed
39051678Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.J Antimicrob Chemother2024https://conductscience.org/library/papers/39051678PubMed
39048999Prevalence of rectal carbapenem resistant Enterobacterales carriage among patients attending healthcare facilities in Ibadan, Nigeria: a descriptive study.BMC Infect Dis2024https://conductscience.org/library/papers/39048999PubMed
38254025An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study.BMC Infect Dis2024https://conductscience.org/library/papers/38254025PubMed
38222461Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates-SMART United States 2019-21.JAC Antimicrob Resist2024https://conductscience.org/library/papers/38222461PubMed
38098829Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children.Front Public Health2023https://conductscience.org/library/papers/38098829PubMed
37824582The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa.PLoS One2023https://conductscience.org/library/papers/37824582PubMed
37533805Antimicrobial stewardship in the intensive care unit.J Intensive Med2023https://conductscience.org/library/papers/37533805PubMed
37215420Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit.World J Clin Cases2023https://conductscience.org/library/papers/37215420PubMed
37192202Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex.PLoS One2023https://conductscience.org/library/papers/37192202PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34673293

GET https://conductscience.org/api/papers/v1/34673293/cited_by?page=2